Total Funding
$15M
Employee Range
11-50
Allysta specializes in developing innovative medicines for fibrosing diseases and ocular surface inflammations. Their products boast anti-inflammatory, anti-fibrotic, and cell-regenerative properties, offering significant potential for treating a variety of conditions and enhancing metabolic health.
Allysta data powered by:
Share
Allysta data powered by:
AllystaOverall Ranking
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
AllystaIndustry Rankings in
Healthtech
City Rank
Share
3rd
In Bellevue
Top 30%out of 10 startups
National Rank
Share
3,670th
In United States
Top 42%out of 8869 startups
Regional Rank
Share
3,875th
In North America
Top 41%out of 9666 startups
AllystaSubindustry Rankings in
BiotechnologyCity Rank
Share
1st
In Bellevue
Top 100%out of 1 startups
National Rank
Share
1,622nd
In United States
Top 47%out of 3470 startups
Regional Rank
Share
1,695th
In North America
Top 46%out of 3719 startups
rankings by:
AllystaSB Rank Evolution
Not enough data points to display the chart.
AllystastartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro